Epivotide

伊匹乌肽

Report date: 2025/04/24 14:14:55
NME

Base Information

Drug NameEpivotide
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionPhosphatidylinositol 3 kinase gamma inhibitors
TargetsPhosphatidylinositol-4,5-Bisphosphate 3 kinase gamma
Therapy Area/IndicationsInflammationKeratitisCorneal Diseases +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesWuhan Yicheng Biotechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesWenzhou Yicheng Jingzhan Biological Technology Co LtdYicheng Kangtai (Xiamen) Biotechnology Co LtdShenzhen Yixinkang Biotechnology Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsInflammationKeratitisCorneal Diseases +[8] 
Inactive IndicationsConjunctivitis, AllergicNasal ObstructionSinusitis +[4] 

Other Information

ATC CodeN/A
Related LinksN/A